Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

CONTEXT: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke or transient ischemic attack (TIA) but is associated with increased risk for bone fracture. OBJECTIVE: To characterize fractures associated with pioglitazone by location, mechanism, severity, timing, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Viscoli, Catherine M., Inzucchi, Silvio E., Young, Lawrence H., Insogna, Karl L., Conwit, Robin, Furie, Karen L., Gorman, Mark, Kelly, Michael A., Lovejoy, Anne M., Kernan, Walter N.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2016
Assuntos:
Clinical Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460686/
https://ncbi.nlm.nih.gov/pubmed/27935736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-3237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados